Stay updated on ED-SCLC Immuno-Therapy Clinical Trial

Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:19:43.000Z thumbnail image
  2. Check
    19 days ago
    Change Detected
    Summary
    Added related topics: Lung cancer and MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-02-26T13:33:34.000Z thumbnail image
  3. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1. No observable changes to the study content or layout.
    Difference
    0.0%
    Check dated 2026-02-12T01:54:13.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1, indicating a minor page/version update.
    Difference
    0.0%
    Check dated 2026-02-05T00:27:48.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    UI and labeling updates were applied: a Show glossary option is now available on the page, the QC date label now reads 'Last Update Submitted that Met QC Criteria', and 'No FEAR Act Data' with the revision tag 'v3.4.0' were added. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.1%
    Check dated 2026-01-28T21:32:22.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Removed the 'Lung cancer' and 'MedlinePlus Genetics' related topics from the study's related topics section. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-21T06:36:58.000Z thumbnail image

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.